BiotechTube
Home/Mauna Kea Technologies/Christopher D. McFadden, CFA
CD

Christopher D. McFadden, CFA

Member of the Board

Mauna Kea Technologies

Therapeutic Areas

GastroenterologyPulmonologyUrologyNeurosurgeryOncology

Mauna Kea Technologies Pipeline

DrugIndicationPhase
Cellvizio for Pancreatic CystsCharacterization of Pancreatic Cystic LesionsClinical Validation
CellToleranceFood Intolerance (e.g., IBS)Commercial Launch
Cellvizio in Uro-oncologyBladder/Prostate Cancer VisualizationPartnership Development
Cellvizio in NeurosurgeryBrain Tumor Margin DelineationPartnership Development
Cellvizio in PulmonologyLung Nodule CharacterizationPartnership Development
AI IntegrationImage Analysis Across IndicationsR&D

Leadership Team at Mauna Kea Technologies

SL
Sacha Loiseau, Ph.D.
Founder, Chairman of the Board and CEO
MO
Molly O'Neill
Member of the Board
CB
Claire Biot
Member of the Board
JT
Jacquelien ten Dam
Member of the Board
View full Mauna Kea Technologies profile